Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Tenaya Therapeutics Inc (TNYA)

Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire - Tue Nov 19, 7:00AM CST

TNYA : 2.38 (+10.19%)
Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update GlobeNewswire - Wed Nov 6, 3:05PM CST

TNYA : 2.38 (+10.19%)
Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM GlobeNewswire - Thu Oct 17, 3:30PM CDT

TNYA : 2.38 (+10.19%)
Why This Nasdaq Stock Caught Fire This Week Motley Fool - Thu Apr 20, 2023

A wave of bargain buying benefited the gene therapy company's shares this week.

BLU : 14.74 (unch)
RXDX : 199.92 (+0.09%)
TNYA : 2.38 (+10.19%)
Tenaya Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update Globe Newswire - Wed Aug 10, 2022

Received State Licensing to Enable cGMP Manufacturing of Drug Product TN-201 and TN-301 IND Submissions on Track for Second Half 2022 Presented...

TNYA : 2.38 (+10.19%)
Tenaya Therapeutics Publishes Preclinical Data in Science Translational Medicine Detailing Discovery of HDAC6 Inhibitor for Treatment of Heart Failure Globe Newswire - Wed Jul 6, 2022

Tenaya’s Precision Medicine Platform Used to Identify HDAC6 Target Using Phenotypic Screening and Machine Learning Algorithms Tenaya’s HDAC6 Inhibitor...

TNYA : 2.38 (+10.19%)
Tenaya Therapeutics Launches Operations of New Genetic Medicines Manufacturing Center to Support the Development of Potentially First-In-Class Cardiovascular Therapeutics Business Wire - Thu Jun 16, 2022

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced...

TNYA : 2.38 (+10.19%)
Tenaya Therapeutics to Present Preclinical Data on TN-301 HDAC6 Inhibitor at European Society of Cardiology Heart Failure 2022 Conference Business Wire - Fri May 20, 2022

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced that...

TNYA : 2.38 (+10.19%)
Tenaya Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update Business Wire - Wed May 11, 2022

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today...

TNYA : 2.38 (+10.19%)
Tenaya Therapeutics to Present Preclinical Data on Gene Therapy Programs and Platform Capabilities at the American Society of Gene and Cell Therapy 25th Annual Meeting Business Wire - Tue May 3, 2022

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced that...

TNYA : 2.38 (+10.19%)

Barchart Exclusives

Thanksgiving, GDP and Other Key Things to Watch This Week Barchart - Sun Nov 24, 2:00PM CST
This week is a short week with the holiday, but there are still plenty of things to watch on the news front. In addition, there is increasing tension overseas again as the Russia/Ukraine conflict appears to be getting more intense. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot